Pulse Biosciences, Inc.
Pulse Biosciences, Inc. (PLSE) Stock Forecast & Analyst Price Target
Wall Street consensus, 12-month price targets, model projections, and EPS/revenue estimates — from analyst data and price history.
plse · stock forecast · 4 analysts (3M) · FMP · updated Jun 8, 2026
Analyst Rating & Consensus
Based on 4 Wall Street analysts in the past 3 months
Buy
4 analysts
consensus
Rating Breakdown
12-Month Price Target
High
$32.00
Consensus
$30.67
+20.5% upside
Low
$30.00
Median: $30 · Last Close: $25.46
12-Month Price Target Forecast
Historical closing prices + analyst 12-month price target forecast cone
Consensus Target
$30.67
20.5% upside
High Target
$32
25.7%
Low Target
$30
17.8%
Current Price
$25.46
as of today
Based on analyst price targets, the PLSE stock price prediction for the next 12 months ranges from $30 to $32. The consensus PLSE price forecast of $30.67 implies 20.5% upside from the current price of $25.46.
Short-Term Price Prediction
BullAlgorithmically generated · Updated daily
| Date | Predicted Price | Change |
|---|---|---|
| 2026-06-09 | $25.92 | ↑ 1.81% |
1-day model range: $25.63–$26.22. Peak: $26.22 (+1.81%).
Long-Term Stock Price Prediction
Stock Forecast Based on Technical Analysis
14 TA signals (SMA×6 + EMA×6 + RSI + MACD) · EEAT method transparency
Market Sentiment
BULLISH
Based on 14 technical indicators
Refreshes daily from EOD close
Moving Averages · PLSE · Jun 8, 2026
Latest Analyst Ratings & Upgrades
| Date | Brokerage | Action | Rating |
|---|---|---|---|
| 2022-09-21 | Maxim Group | Downgrade ↓ | Buy→Hold |
| 2022-05-13 | HC Wainwright & Co. | Downgrade ↓ | Buy→Neutral |
| 2022-04-01 | Stephens & Co. | Maintains | Overweight→Overweight |
| 2022-04-01 | HC Wainwright & Co. | Maintains | Buy→Buy |
| 2022-02-10 | HC Wainwright & Co. | Maintains | Buy→Buy |
| 2021-11-16 | HC Wainwright & Co. | Maintains | Buy→Buy |
| 2021-07-27 | Stephens & Co. | Maintains | Overweight→Overweight |
| 2021-03-11 | Maxim Group | Maintains | Buy→Buy |
| 2021-01-26 | HC Wainwright & Co. | Maintains | Buy→Buy |
| 2020-05-12 | H.C. Wainwright | Upgrade ↑ | Neutral→Buy |
Wall Street analysts have recently issued updated ratings on Pulse Biosciences, Inc. (PLSE) stock. Of the recent 14 rating actions, 2 were upgrades and 4 were downgrades. 4 analysts currently cover PLSE.
Analyst Recommendation Trends
PLSE analyst recommendation trends show decreasing buy-side sentiment over the past 6 months. Buy rating actions changed from 1 to 0 per month.
Financial Forecast: EPS & Revenue Estimates
Revenue This Year
$3M
↓ 92.3% YoY
Revenue Next Year
$13M
↑ 296.8% YoY
EPS This Year
$-1.10
EPS Next Year
$-1.15
↑ 4.5% YoY
EPS ForecastReported vs Estimated
Analysts forecast PLSE EPS of $-1.10 for the current fiscal year, based on estimates from 1 analysts. The PLSE revenue forecast is $3M for the current year. These are analyst consensus estimates via FMP / S&P Global.
About Forecast & Price Prediction
The PLSE stock forecast is supported by two independent data sources: analyst consensus ratings from 4 Wall Street analysts (S&P Global / FMP), and technical analysis calculated from historical EOD price data. The consensus PLSE price target is $30.67 (+20.5% upside), with an analyst consensus of Buy.
The PLSE short-term stock prediction for tomorrow is $25.92 (+1.81%).
Pulse Biosciences, Inc. trades on NASDAQ under the ticker PLSE. The PLSE stock outlook for 2027 is broadly positive, supported by a Buy consensus among 50% of covering analysts.
Frequently asked questions
PLSE forecast · 8 questionsAccording to 4 Wall Street analysts, the average 12-month PLSE price target is $30.67, with a high forecast of $32.00 and a low of $30.00. The median price target is shown in the chart above when available. This implies +20.5% potential upside from the current price of $25.46.
· Analyst data: Financial Modeling Prep (FMP) · S&P Global Market Intelligence · Technical analysis: FMP /historical-price-eod/light · Updated: Hourly (analyst) · Daily (technical)
⚠ This information is provided for informational purposes only and does not constitute investment advice. Short-term and long-term price predictions are algorithmically generated and carry significant uncertainty. Past performance does not guarantee future results. Always conduct your own due diligence before making investment decisions.